(19)
(11) EP 1 220 681 A2

(12)

(88) Date of publication A3:
20.09.2001

(43) Date of publication:
10.07.2002 Bulletin 2002/28

(21) Application number: 00960250.9

(22) Date of filing: 18.09.2000
(51) International Patent Classification (IPC)7A61K 38/17, C12N 5/06, C07K 14/435, A61P 25/00
(86) International application number:
PCT/CA0001/049
(87) International publication number:
WO 0119/851 (22.03.2001 Gazette 2001/12)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 16.09.1999 US 154668 P

(71) Applicant: Prescient Neuropharma Inc.
Etobicoke,Ontario M9W 4Y9 (CA)

(72) Inventors:
  • COMMISSIONG, John
    Mississauga, Ontario L5B 3Y7 (CA)
  • RAIBEKAS, Andrei, A.
    Toronto, Ontario M6P 1G2 (CA)

(74) Representative: Becker, Philippe et al
Cabinet Becker & AssociƩs35, rue des Mathurins
75008 Paris
75008 Paris (FR)

   


(54) OPAMINERGIC NEURONAL SURVIVAL-PROMOTING FACTORS AND USES THEREOF